A Complimentary Joint Webinar with ISPE San Diego and ISPE Los Angeles Chapters A Perspective from the Broker, Land Developer & Asset Manager Curious What the Current State of the Life Science Real Estate Market is in Southern California?
The Life Science Industry has been Booming and Evolving Quickly While also Adapting to Unforeseen Circumstances. Join Us and Hear from Key Stakeholders to Gain Valuable Insight Into the Current Real Estate Market Conditions and Predictions for the Future.
Greg Bisconti, Executive Director, National Practice Group Leader, Cushman & Wakefield Greg Bisconti specializes exclusively in representing life science clients, focusing on tenant representation for the complex needs of small start-ups, fast growth companies, and large pharma clients. He has been personally involved in over 12 million square feet of lease and/or sale transactions, valued at over $4B in consideration, including cGMP manufacturing assignments and other special purpose facilities.
Starting with C&W in 1994, Greg has enjoyed a 20+ year career with Cushman & Wakefield and is a leader of its National Life Sciences Advisory Group. His clients have included Dexcom, Biogen Idec, Takeda, Synthetic Genomics, Inception Sciences, UCSD, BASF, Genomatica, Pfizer, Eli Lilly, Alexandria Real Estate Equities, Illumina, and a variety of cutting edge start-ups, such as Quanticel, Metacrine, Organovo, and Ideaya, to name a few. Greg started at Cushman & Wakefield’s San Francisco office in 1994 as a financial analyst and later moved on to leasing and sales, ultimately focusing on tenant representation. He received his Bachelor of Science in Business Administration with a concentration in Real Estate and Urban Land Use from California State University, Sacramento.
Nick Frasco, Managing Director, Longfellow Real Estate Partners, LLC Nick oversees Longfellow's strategic growth and operations of the West Coast portfolio. Prior to joining Longfellow, Nick served as Senior Director in the San Diego office of real estate capital markets intermediary HFF, where he was responsible for over $2 billion of life science, office, and industrial investment sales. He is a 2007 graduate of the University of Southern California, Marshall School of Business, BSBA Real Estate Development.
Tony Wei, Vice President, Strategic Transactions & Analysis, Alexandria Real Estate Equities Tony Wei is a Vice President of Strategic Transactions & Analysis at Alexandria Real Estate Equities, an urban life science and office REIT with over $18 billion (“BN”) assets under management (“AUM”). He is involved in every aspect of acquisitions and development across the entire risk spectrum (Core, Value Add, and Opportunistic) and is responsible for overseeing acquisitions and asset management for Alexandria's LA region.
Tony helps manage redevelopments from market research, site identification, negotiation and acquisition, to project kickoff. He assists in design and entitlement efforts, analyzes market comps to inform underwriting assumptions, benchmarks development costs and returns to comparable projects to identify cost savings, and collaborates with consultants to obtain cost estimates and projects schedules. For acquisitions, Tony evaluates and underwrites transactions, negotiates and structures purchase agreements, performs detailed due diligence, and prepares and presents investment memos. After closing, Tony continues to monitor assets by analyzing and structuring new leases and updating development costs projections until each property is stabilized.
Prior to joining ARE in 2010, Tony consulted for American Realty Advisors, a real estate investment manager with over $8 BN AUM. He helped managed office, industrial, and retail assets for American around Los Angeles, Orange County, and San Diego. Prior to that, he worked in the dispositions department at NNN, a 1031 Exchange company with over $3BN AUM, where he prepared cash flows, due diligence documents, and Offering Memorandums for potential dispositions. Tony began his career at Grant Thornton as an audit associate and is a CPA (non-active).
Tony obtained a M.B.A. from the Anderson School of Management at UCLA and a B.A. in Economics from University of California at Berkeley.
When the State of California lifts restrictions, new dates will be announced. Although golf courses are open, large golf tournaments are not yet permitted. Official statement from the State of California:
The California Department of Public Health has determined that all public gatherings with people who are not members of your household—in any indoor or outdoor space—should be postponed or canceled to curb community spread of COVID-19. State agencies are not issuing permits for any gatherings—of any size, or any kind—at this time. Gatherings will be permitted again once public health officials determine they can be conducted in a manner consistent with public health and safety.
Golf Tournaments: California is in Stage 2 or 3 (varies county by county) of Stay At Home Orders. While some outdoor activities are allowed in these phases, large groups such as golf tournaments are still off-limits. The current direction says "social and group gatherings are not permitted" and allows golfing as long as each player either walks the course or is in a separate cart and all players maintain social distancing.
Vendor Night and Face-to-face meetings: Large groups events will not take place until Phase 4, which is the end of Stay At Home Order. Stage 4 which requires a therapeutic solution to the disease